# OnCo record triarm-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/triarm-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "triarm-therapeutics" ;
  schema:name "TriArm Therapeutics"@en ;
  schema:alternateName "創恩生技醫藥"@en ;
  schema:description "TriArm Therapeutics develops CAR-T cell therapy made with a faster, virus-free manufacturing process. Its first product, ARM011, targets CD19 and is in an early trial in adults with B-cell acute lymphoblastic leukaemia that has come back or not responded."@en ;
  schema:url <https://onco.cc/companies/triarm-therapeutics/>, <https://www.triarm.com.tw/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.triarm.com.tw/>, <https://clinicaltrials.gov/study/NCT07066397> ;
  schema:addressCountry "TW" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/> .